Comparative effectiveness and safety of atorvastatin versus rosuvastatin among patients with ischemic stroke or transient ischemic attack: a national registry-based observational study
This work was supported by National Key Research and Development Program of China (2022YFC2502400, 2022YFC2502404), Beijing Natural Science Foundation Haidian original innovation joint fund (L222123), and Youth Innovation Fund of Beijing Neurosurgical Institute (2025 Reform and Development-Youth 15).
Authors
- Xue Tian (ORCID: https://orcid.org/0000-0001-9164-3631)
- X. H. Li (ORCID: https://orcid.org/0000-0001-7969-644X)
- Xue Xia (ORCID: https://orcid.org/0000-0002-8318-7880)
- Qin Xu (ORCID: https://orcid.org/0000-0002-8039-709X)
- Ruhui Tian (ORCID: https://orcid.org/0000-0001-5709-1175)
- Xiaoli Zhang (ORCID: https://orcid.org/0000-0002-0770-5594)
- Jianhua Zhao (ORCID: https://orcid.org/0000-0003-2269-3963)
- Anxin Wang (ORCID: https://orcid.org/0000-0003-4351-2877)
- Meng Xia (ORCID: https://orcid.org/0000-0002-9711-6215)
Institutions
- Capital Medical University (CN)
- Beijing Tian Tan Hospital (CN)
- Beijing Institute of Neurosurgery (CN)
- Henan Medical University (CN)
Publication Details
- Journal
- EClinicalMedicine
- Published
- 2025-07-24
- DOI
- https://doi.org/10.1016/j.eclinm.2025.103381
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Key Research and Development Program of China